A citation-based method for searching scientific literature

Ayse Mavi, Tevfik F Cermik, Muammer Urhan, Halis Puskulcu, Sandip Basu, Jian Q Yu, Hongming Zhuang, Brian Czerniecki, Abass Alavi. J Nucl Med 2007
Times Cited: 63



Rakesh Kumar, Anil Chauhan, Hongming Zhuang, Prem Chandra, Mitchell Schnall, Abass Alavi. Breast Cancer Res Treat 2006
Times Cited: 135




List of shared articles



Times cited

Tumor characteristics and metabolic quantification in carcinoma breast: An institutional experience.
I P Dubey, A Jain, M S Chauhan, R Kumar, S Agarwal, B Kishore, M G Vishnoi, D Paliwal, A R John, N Kumar,[...]. Indian J Cancer 2017
2


Can 18F-FDG PET improve the evaluation of suspicious breast lesions on MRI?
Almir G V Bitencourt, Eduardo N P Lima, Rubens Chojniak, Elvira F Marques, Juliana A Souza, Wesley P Andrade, Marcos D Guimarães. Eur J Radiol 2014
13

The Relationship Between Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Expression of Breast Cancer and the Retention Index in Dual Phase (18)F-FDG PET/CT.
Hansol Moon, Woo Chul Noh, Hyun-Ah Kim, Eun-Kyu Kim, Ko Woon Park, Seung Sook Lee, Joon Ho Choi, Kyung Woo Han, Byung Hyun Byun, Ilhan Lim,[...]. Nucl Med Mol Imaging 2016
6

18F-FDG PET-CT imaging in the neoadjuvant setting for stages II-III breast cancer: association of loco‑regional SUVmax with classical prognostic factors.
M García García-Esquinas, J A García-Sáenz, J Arrazola García, M Enrique Fuentes Ferrer, V Furió, C Rodriguez Rey, J M Román, J L Carreras Delgado. Q J Nucl Med Mol Imaging 2014
14

[PET/CT in breast cancer: an update].
D Groheux, J-L Moretti, S Giacchetti, E Hindié, P Teyton, C Cuvier, G Bousquet, J-L Misset, C Boin, M Espié. Bull Cancer 2009
7


Correlation between PET/CT results and histological and immunohistochemical findings in breast carcinomas.
Almir Galvão Vieira Bitencourt, Eduardo Nóbrega Pereira Lima, Rubens Chojniak, Elvira Ferreira Marques, Juliana Alves de Souza, Luciana Graziano, Wesley Pereira Andrade, Cynthia Aparecida Bueno de Toledo Osório. Radiol Bras 2014
21


Performance of FDG PET/CT in the clinical management of breast cancer.
David Groheux, Marc Espié, Sylvie Giacchetti, Elif Hindié. Radiology 2013
150

Correlation of Molecular Subtypes of Invasive Ductal Carcinoma of Breast with Glucose Metabolism in FDG PET/CT: Based on the Recommendations of the St. Gallen Consensus Meeting 2013.
Sun Seong Lee, Sang Kyun Bae, Yun Soo Park, Ji Sun Park, Tae Hyun Kim, Hye Kyoung Yoon, Hyo Jung Ahn, Seok Mo Lee. Nucl Med Mol Imaging 2017
12

Imaging features of HER2 overexpression in breast cancer: a systematic review and meta-analysis.
Sjoerd G Elias, Arthur Adams, Dorota J Wisner, Laura J Esserman, Laura J van't Veer, Willem P Th M Mali, Kenneth G A Gilhuijs, Nola M Hylton. Cancer Epidemiol Biomarkers Prev 2014
41

Evaluation of the association between HIF-1α and HER-2 expression, hormone receptor status, Ki-67 expression, histology and tumor FDG uptake in breast cancer.
Sevi M Sureyya Cerci, Kemal Kursat Bozkurt, Hasan Erol Eroglu, Celal Cerci, Evrim Erdemoglu, Pinar Talip Bulbul, Meltem Cetin, Recep Cetin, Ibrahim Metin Ciris, Mahmut Bulbul. Oncol Lett 2016
4

Ductal carcinoma in situ and ductal carcinoma in situ with microinvasion: correlation of FDG uptake with histological and biological prognostic factors.
Ye Young Seo, Ie Ryung Yoo, Sonya Youngju Park, Jin Kyoung Oh, Sung Hoon Kim, Hyung Sun Sohn. Breast Cancer 2017
3

Positron emission mammography: correlation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status and 18F-FDG.
Carolyn L Wang, Lawrence R MacDonald, James V Rogers, Aleksandr Aravkin, David R Haseley, J David Beatty. AJR Am J Roentgenol 2011
46

18F-FDG semi-quantitative parameters and biological prognostic factors in locally advanced breast cancer.
A M García Vicente, A Soriano Castrejón, F Relea Calatayud, V Muñoz Madero, M J Molina Garrido, A A León Martín, J M Cordero García, J P Pilkington Woll, I Chacón López-Muñiz, A Palomar Muñoz. Rev Esp Med Nucl Imagen Mol 2012
17

Diagnostic Performance of [18F]FDG PET in Staging Grade 1-2, Estrogen Receptor Positive Breast Cancer.
Ramsha Iqbal, Lemonitsa H Mammatas, Tuba Aras, Wouter V Vogel, Tim van de Brug, Daniela E Oprea-Lager, Henk M W Verheul, Otto S Hoekstra, Ronald Boellaard, Catharina W Menke-van der Houven van Oordt. Diagnostics (Basel) 2021
1

Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.
David Groheux, Sylvie Giacchetti, Jean-Luc Moretti, Raphael Porcher, Marc Espié, Jacqueline Lehmann-Che, Anne de Roquancourt, Anne-Sophie Hamy, Caroline Cuvier, Laetitia Vercellino,[...]. Eur J Nucl Med Mol Imaging 2011
255